Skip to main content
HOSHIIRYO-SANKI CO., LTD. logo

HOSHIIRYO-SANKI CO., LTD. — Investor Relations & Filings

Ticker · 7634 ISIN · JP3845750003 T Human health and social work activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2024-02-13 Report Publication Anno…
Country JP Japan
Listing T 7634

About HOSHIIRYO-SANKI CO., LTD.

https://www.hosi.co.jp/

HOSHIIRYO-SANKI CO., LTD. is a specialized manufacturer and supplier of pharmaceutical medical gases, including oxygen, nitrous oxide, nitrogen, and carbon dioxide. The company's operations are centered around two main business areas: medical gas and home medical care. The medical gas segment involves the production and supply of gases to healthcare facilities, along with the maintenance of related equipment. The home medical care segment provides comprehensive support for patients requiring therapies such as Home Oxygen Therapy (HOT), Continuous Positive Airway Pressure (CPAP), and Home Mechanical Ventilation (HMV). The company also engages in the nursing care and welfare equipment business, supported by a 24-hour, year-round service infrastructure.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is extremely short (890 chars) and contains a header section indicating it is a '確認書' (Confirmation Document) submitted to the Kanto Local Finance Bureau Director based on Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act. The main body explicitly states that the Representative Director confirmed the appropriateness of the '第50期第３四半期（自 2023年10月１日 至 2023年12月31日）の四半期報告書' (The Quarterly Report for the 3rd Quarter of the 50th Period). This structure—a short confirmation document related to a specific periodic report (Quarterly Report)—strongly suggests this is an announcement or certification related to the filing, rather than the comprehensive report itself. Since the document confirms the accuracy of a Quarterly Report (Interim Report), and it is a short confirmation notice, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not the full Interim Report (IR) or an Earnings Release (ER), but a procedural filing related to it. Given the context of Japanese filings, this confirmation document is a specific regulatory submission that doesn't map perfectly to the provided definitions other than as a general regulatory filing.
2024-02-13 Japanese
四半期報告書－第50期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the consolidated balance sheet and management analysis for the third quarter of the 50th fiscal period (ending December 31, 2023). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. 9M 2024
2024-02-13 Japanese
臨時報告書
M&A Activity Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau on December 8, 2023. The primary content details the resolution by the Board of Directors to absorb and merge two wholly-owned subsidiaries (株式会社星医療酸器関西 and 株式会社星医療酸器東海) effective April 1, 2024. This filing explicitly references regulations concerning changes in specified subsidiaries and absorption-type mergers under Japanese financial instruments and exchange laws (企業内容等の開示に関する内閣府令第19条第２項第３号及び第７号の３). This type of mandatory disclosure regarding significant corporate restructuring, such as a merger involving subsidiaries, is typically classified as a general Regulatory Filing (RNS) in the absence of a more specific category like M&A Activity (TAR), which usually applies to third-party takeovers or major acquisitions. Since this is a mandatory disclosure document detailing a corporate action (merger) and is not a standard periodic report (10-K, IR) or an announcement of a report (RPA), RNS is the most appropriate general regulatory filing category.
2023-12-08 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification by the CEO of Hoshi Iryo-Sanki Co., Ltd., confirming the accuracy of the contents of the quarterly report for the second quarter of the 50th fiscal period. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS). Q2 50
2023-11-14 Japanese
四半期報告書－第50期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet, income statement, and cash flow analysis for the second quarter of the 50th fiscal period (April 1, 2023, to September 30, 2023). It includes audit review information and management's analysis of financial results, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2023-11-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, Article 24-4-8, Paragraph 1. It serves as an officer certification by the CEO of Hoshi Iryo-Sanki Co., Ltd. confirming the accuracy of the quarterly report. Per the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report, should be classified as Regulatory Filings (RNS) rather than the report itself. Q1 50
2023-08-10 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.